Research progress on clinical application of anti-tissue factor pathway inhibitor in hemophilia
In recent years, to address the unmet needs in hemophilia treatment, significant research has led to unprecedented advances in pharmacotherapy, including the development of several innovative mechanism-based therapies that restore hemostatic balance by modulating thrombin generation in hemophilia pa...
Saved in:
| Main Author: | XIAO Jianwen, YI Weijia |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Diagnostics Concepts & Practice
2025-04-01
|
| Series: | Zhenduanxue lilun yu shijian |
| Subjects: | |
| Online Access: | https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1752188894086-415047184.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Marstacimab for the Treatment of Hemophilia A or B
by: Mahlangu J
Published: (2025-06-01) -
Exploration of biomarkers for inhibitor development in persons with hemophilia A
by: Meng-Ni Fan, et al.
Published: (2025-05-01) -
Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia
by: R. I. Yagudina, et al.
Published: (2015-03-01) -
Acquired Hemophilia A successfully treated with rituximab
by: Giovanni D'Arena, et al.
Published: (2015-02-01) -
Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)
by: Ragnhild J. Måseide, MD, PhD, et al.
Published: (2024-11-01)